Investor Presentation. November 26, 2013
|
|
- Bennett Flowers
- 6 years ago
- Views:
Transcription
1 Investor Presentation November 26, 2013
2 Forward-Looking Statements This presentation may contain forward-looking statements as defined under U.S. federal securities laws. These statements reflect management's current knowledge, assumptions, beliefs, estimates, and expectations and express management's current view of future performance, results, and trends. Forward-looking statements may be identified by their use of terms such as anticipate, believe, could, estimate, expect, intend, may, plan, predict, project, will, and other similar terms. Forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to materially differ from those described in the forward-looking statements. The reader should not place undue reliance on forward-looking statements. Such statements are made as of the date of this presentation, and we undertake no obligation to update such statements after this date. Risks and uncertainties that could cause our actual results to materially differ from those described in forward-looking statements are discussed in our filings with the Securities and Exchange Commission (including those described in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2012, and as may be supplemented in our Quarterly Reports on Form 10-Q). By way of example and without implied limitation, such risks and uncertainties include: failure to realize the anticipated benefits of the Biotech International acquisition in whole or in part, and unexpected liabilities and/or erroneous financial estimates and projections for the acquired business; failure to realize the anticipated financial and other benefits from the acquisition of BioMimetic Therapeutics, Inc. or a delay in realization thereof; failure to obtain, or a delay in obtaining, FDA approval of Augment Bone Graft, or a material limitation on the scope of such approval; lower than anticipated market acceptance of, or annual market demand for, Augment Bone Graft; failure to obtain necessary approvals, or other intervening events, which could delay or prevent the previously announced sale of our hip/knee business from closing; future actions of the United States Attorney's office, the FDA, the Department of Health and Human Services or other U.S. or foreign government authorities, including those resulting from increased scrutiny under the Foreign Corrupt Practices Act and similar laws, that could delay, limit or suspend our development, manufacturing, commercialization and sale of products, or result in seizures, injunctions, monetary sanctions or criminal or civil liabilities; failure to obtain the FDA or other regulatory clearances needed to market and sell our products; any actual or alleged breach of the Corporate Integrity Agreement to which we are subject through September 2015 which could expose us to significant liability including exclusion from Medicare, Medicaid and other federal healthcare programs, potential criminal prosecution, and civil and criminal fines or penalties; adverse outcomes in existing product liability litigation; new product liability claims; inadequate insurance coverage; the possibility of private securities litigation or shareholder derivative suits; demand for and market acceptance of our new and existing products; potentially burdensome tax measures; recently enacted healthcare laws and changes in product reimbursement which could generate downward pressure on our product pricing; lack of suitable business development opportunities; inability to capitalize on business development opportunities; product quality or patient safety issues; challenges to our intellectual property rights; geographic and product mix impact on our sales; our inability to retain key sales representatives, independent distributors and other personnel or to attract new talent; inventory reductions or fluctuations in buying patterns by wholesalers or distributors; inability to realize the anticipated benefits of restructuring initiatives; negative impact of the commercial and credit environment on us, our customers and our suppliers; and the potentially negative effect of our ongoing compliance enhancements on our relationships with customers and our ability to deliver timely and effective medical education, clinical studies, and new products. 2
3 Use of Non-GAAP Financial Measures Wright Medical uses certain non-gaap financial measures in this presentation. Wright Medical uses non-gaap financial measures as supplemental measures of performance and believes these measures provide useful information to investors in evaluating our operations, period over period. However, non-gaap financial measures have limitations as analytical tools, and should not be considered in isolation or as a substitute for or as superior to Wright Medical s financial results prepared in accordance with GAAP. In addition, investors should note that any non-gaap financial measures Wright Medical uses may not be the same non-gaap financial measures, and may not be calculated in the same manner, as that of other companies. We have posted a reconciliation of our non-gaap financial measures to the most directly comparable GAAP financial measures on our website at 3
4 Wright Medical: A Leader in Our Space Orthopaedic medical device company Global Sales from continuing operations 2013E ~$238M (1) Market cap (as of 11/26/13) ~$1.4B Countries >60 1 Midpoint of guidance range communicated on 11/4/2013. The fact that we include these projections in this presentation should not be taken to mean that these amounts continue to be our projections as of any subsequent date. 4
5 W R I G H T M E D I C A L Historically Positioned in Two Large Markets Business Market Size / Growth Our Position / Strategic Focus Extremities (incl. Biologics) ~45% of sales Size: ~$3.5B (1) Market Growth: ~8-10% Recognized leader in Foot & Ankle Primarily US Focus: growth Ortho-Recon (Hips and Knees) ~55% of sales Size: ~$13B (2) Market Growth: ~0-3% Mid-sized player Primarily International Focus: efficiency, cash generation 1 US Market 2012 Millennium Research Group, Management Estimates 2 Worldwide Market 2011 Millennium Research Group, Management Estimates 5
6 Entered Into Agreement to Divest OrthoRecon Business June 19, 2013: Wright and MicroPort Scientific Corporation Enter Into Definitive Agreement Under Which MicroPort Will Acquire Wright s OrthoRecon Business Transaction transforms Wright Medical into high-growth Extremities and Biologics pure play Purchase price of $290 million in cash, subject to a net working capital adjustment Expect to close by end of Q4 of
7 L A S T T W O Y E A R S A Transformed Business High Growth Profile Wright Medical Focus on strengthening Extremities Divest slower growth OrthoRecon segment Low Low Business Focus High 7
8 Focused On Higher Growth Segments of the Orthopedics Market CAGR 10% 7-8% 7% 7% 6% 3-4% 3% 2-3% Foot & Ankle Sports Medicine Biologics Extremities Trauma Knee Spine Hip Source: 2011 & 2012 Millennium Research Group, 2012 Life Science Intelligence, Management Estimates 8
9 T R A N S F O R M I N G T H E C O M P A N Y Results Indicate Execution is On Track A Few Key Numbers Increase US Foot and Ankle Sales Productivity Q3, 2013 Continued Investment in Physician Training 2013 Accelerate Growth in Global Foot & Ankle Q3, 2013 Sales from Continuing Operations Q3, 2013 $ 780K ~2, % +14 % vs. $700K in 2012 and $600K in 2011 trained vs. 2,000 in 2012 and 600 in 2011 vs. 14% in Q3, 2012 vs. 2% in Q3,
10 Accelerating Foot & Ankle Growth Foot & Ankle Growth (Global Constant Currency) 23% 15% 9% YTD 3Q
11 T H E M A R K E T Focused on Most Attractive Segment of Extremities Market Breakdown of $3.5B US Extremities Market Foot & Ankle: An Attractive Segment Upper Extremity $2.4B 27,000 surgeons Foot & Ankle $1.1B 7,500 surgeons and podiatrists More concentrated call point Complex treatment issues, less mature products need innovative solutions significant mix opportunity Strong growth drivers trauma osteoarthritis diabetes obesity High margin Source: Millennium Research Group, Management Estimates Underpenetrated market significant opportunity for international expansion 11
12 S T R E N G T H S : Recognized Leader in Foot and Ankle Direct US foot & ankle sales organization Most comprehensive foot & ankle product portfolio Continued investment in R&D VALOR NAIL Fixation INBONE Total Ankle SIDEKICK Fixation AM Surgical Endoscopic Blade CHARLOTTE CLAW 2.7mm Implant DARCO Screws CHARLOTTE CLAW 3.5mm Implant CHARLOTTE Compression SIDEKICK Stealth Fixation CHARLOTTE 7.0 MUC Screw CHARLOTTE Jones Fracture Screw LIS FRANC Plate CHARLOTTE 3.0 MUC Screw BIOFOAM Wedge ORTHOLOC Plate GRAFTJACKET Regenerative Tissue Matrix DART-FIRE Screws ORTHOSPHERE Implant DARCO DPS Plate CHARLOTTE Snap-Off Screw BIOARCH Implant ORTHOLOC Plate SWANSON Hammer Toe Implant ENDO-FUSE Rods and Beams DARCO PIA Plate DARCO LPS Plate PRO-TOE Hammer Toe Fixation LPT Toe Implant DARCO RPS Plate DARCO BOW Plate DARCO MPJ Plate CORETRAK Tube Fixator SWANSON Great Toe MTP Plate 12
13 S T R A T E G I C F O C U S : G R O W T H Maximize the Foot & Ankle Opportunity Grow base business next generation products INBONE II and PROPHECY Total Ankle Replacement System PRO-TOE Hammertoe Fixation System ORTHOLOC 3Di Foot Reconstruction Plating System CLAW II Polyaxial Compression Plating System Our Goal Accelerate Growth in Foot & Ankle Market Planned 2014 launches INFINITY Total Ankle Replacement System, New PRO-TOE offering Continued investment in medical education Targeting >50% increase in US sales force productivity to $1M in 2014 International market development 13
14 What s Next? Near-Term Priorities Improve gross margins Momentum is Building Continued progress on inventory initiatives Targeted M&A International expansion Close MicroPort transaction Productivity gains in US Foot & Ankle 14
15 I N T E R N A T I O N A L E X P A N S I O N : Acquisition of Biotech International November 15, 2013: Wright Completes Acquisition of Biotech International Significantly expands Wright s direct sales channel in France and international distribution network Adds complementary extremity product portfolio to further accelerate growth opportunities in global Extremities business Total consideration up to $80 million: $75M paid at closing (~$55M cash and ~$20M in stock); plus contingent payments of up to $5M cash upon achievement of revenue milestones in 2014 and 2015 All Wright common stock subject to one-year lockup 15
16 A U G M E N T B O N E G R A F T : Status of FDA Appeal of Not Approvable Letter Received Not Approvable Letter for Augment Bone Graft from FDA dated August 6, 2013: FDA stated the following: concerned that the population enrolled was predominantly low risk and, therefore, may not have warranted the use of either autograft or Augment Bone Graft. it will be necessary to perform a new clinical study that evaluates the use of Augment Bone Graft as a substitute for autograft in hindfoot and ankle fusion procedures in a well-defined high-risk target population, where the use of autograft would be clinically warranted. the patient population studied in the clinical study, the amount of graft material implanted, and the uncertainty as to whether any graft material would be needed or if the use of no graft material in a fusion procedure of the hindfoot and ankle in the population studied would have achieved similar results. FDA provided a number of additional observations on clinical study design and results. Wright submitted formal appeal to FDA on Sept 5, 2013 On October 31, 2013, Wright was notified by the FDA that the agency has elected to convene a Dispute Resolution Panel to consider the scientific issues in dispute before making a decision on the Company s request that FDA withdraw its August 6, 2013 not approvable letter for Augment Bone Graft. At this time, no date for when Dispute Resolution Panel will be convened 16
17 2013 Guidance for Continuing Operations Revenue (1) $237M - $240M Adj. EPS (1,2) $(0.55) - $(0.59) 1 Guidance range communicated on 11/4/2013. The fact that we include these projections in this presentation should not be taken to mean that these amounts continue to be our projections as of any subsequent date. 2 Includes stock-based compensation and impact of acquisition of BioMimetic Therapeutics, Inc. 17
18 W H Y I N V E S T I N W R I G H T M E D I C A L Repositioning for Improved Growth and Performance The Strategy The Platform The Future Focused on areas where we can win Building high-growth, pure play Extremities- Biologics business Clear goal improved performance Accelerated growth, improved profitability, strong cash flow 18
19 For additional information, please contact: Julie Tracy Chief Communications Officer (901) NASDAQ: WMGI 19
20 Investor Presentation November 26, 2013
Wright Medical Group, Inc.
Wright Medical Group, Inc. A Global Orthopaedic Medical Device Company We are a global orthopaedic medical device company specializing in the design, manufacture, and marketing of reconstructive joint
More informationTeva Pharmaceutical Industries Ltd. J.P. Morgan Healthcare Conference. Kåre Schultz President and CEO January 7, 2019
Teva Pharmaceutical Industries Ltd. J.P. Morgan Healthcare Conference Kåre Schultz President and CEO January 7, 2019 Cautionary Note Regarding Forward-Looking Statements 2 This presentation contains forward-looking
More informationNuVasive, Inc. Acquisition of Ellipse Technologies, Inc. January 5, 2016
NuVasive, Inc. Acquisition of Ellipse Technologies, Inc. January 5, 2016 Safe Harbor Statements Forward-looking information and non-gaap measures NuVasive, Inc. ( NuVasive, NUVA or the Company ) cautions
More informationAmerisourceBergen. J.P. Morgan Healthcare Conference. Steve Collis, Chairman, President & CEO Tim Guttman, EVP & CFO.
AmerisourceBergen J.P. Morgan Healthcare Conference Steve Collis, Chairman, President & CEO Tim Guttman, EVP & CFO January 10, 2017 Cautionary Note Regarding Forward-Looking Statements Certain of the statements
More information2018 Q1 Investor Relations Presentation
2018 Q1 Investor Relations Presentation Forward Looking Statements This presentation contains forward-looking statements. Statements that are predictive in nature, that depend upon or refer to future events
More informationPerkinElmer Announces Financial Results for the First Quarter 2008
PerkinElmer Announces Financial Results for the First Quarter 2008 -- Revenue of $482 million, up 20% over the prior year -- EPS from continuing operations of $0.20; Adjusted EPS of $0.29, up 21% over
More informationMorgan Stanley Conference. November 15, 2017
Morgan Stanley Conference November 15, 2017 1 Forward Looking Statements Certain statements in this release or presentation, other than purely historical information, including estimates, projections,
More informationDeutsche Bank Health Care Conference
Deutsche Bank Health Care Conference May 8, 2018 NASDAQ: ANIK0 Safe Harbor Statement The statements made in, and during the course of, this presentation that are not statements of historical fact, including
More informationMylan. Raymond James 40 th Annual Institutional Investors Conference March 05, 2019
Mylan Raymond James 40 th Annual Institutional Investors Conference March 05, 2019 Forward-Looking Statements This presentation contains forward-looking statements. These statements are made pursuant to
More informationFORWARD LOOKING STATEMENTS
1 FORWARD LOOKING STATEMENTS Certain statements included in this presentation are "forward-looking statements" within the meaning of the federal securities laws. Forward-looking statements are made based
More informationThird Quarter Fiscal 2013 Performance June 29, Financial results and company highlights Fourth quarter and fiscal year 2013 outlook
Third Quarter Fiscal 2013 Performance June 29, 2013 Financial results and company highlights Fourth quarter and fiscal year 2013 outlook Safe Harbor Statement This presentation contains forward looking
More informationExtreme Networks FQ1 19 Financial Results
Extreme Networks FQ1 19 Financial Results November 2, 2018 Cautionary Statement on Financial Measures Non-GAAP Measures: In preparing the accompanying information, the Company has excluded, where applicable,
More informationINVESTOR PRESENTATION. November 2018
INVESTOR PRESENTATION November 2018 Forward Looking Statements Disclaimer This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act
More informationExtreme Networks FQ4 17 Financial Results
Extreme Networks FQ4 17 Financial Results August 14, 2017 Cautionary Statement on Financial Measures Non-GAAP Measures: In preparing the accompanying information, the Company has excluded, where applicable,
More informationOverview and Progress Update: Medicare Performance Initiative (MPI)
Overview and Progress Update: Medicare Performance Initiative (MPI) Britt Reynolds, President Hospital Operations Scott Richardson, Senior Vice President Operations Finance and Performance Management &
More informationINVESTOR PRESENTATION. February 2019
INVESTOR PRESENTATION February 2019 Forward Looking Statements Disclaimer This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act
More informationR1 to Acquire Intermedix and Selected as RCM Services Provider for Ascension Physician Business
R1 to Acquire Intermedix and Selected as RCM Services Provider for Ascension Physician Business Investor Presentation February 26, 2018 Forward-Looking Statements and Non-GAAP Financial Measures This presentation
More informationJefferies TMT Conference
Jefferies TMT Conference Tarek Sherif, Chairman and CEO Cory Douglas, CFO May 9, 2013 2013 Medidata Solutions, Inc. 1 Safe Harbor Statement This presentation contains forward-looking statements within
More informationGeneral Employment Announces Results for Fiscal 2015 Fourth Quarter and Year End
December 30, 2015 General Employment Announces Results for Fiscal 2015 Fourth Quarter and Year End Company Provides Combined Select Pro Forma Financial Information NAPERVILLE, IL -- (Marketwired) -- 12/30/15
More informationQ Earnings Presentation. July 18 th, 2014
Q2 2014 Earnings Presentation July 18 th, 2014 The SAFE HARBOR Statement under the Private Securities Litigation Reform Act of 1995 Statements included in this announcement that are not historical facts
More informationJefferies London Healthcare Conference Julie Brown, CFO
Jefferies London Healthcare Conference Julie Brown, CFO Forward looking statements This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding
More informationJ.P. Morgan Healthcare Conference January 10, 2018
J.P. Morgan Healthcare Conference January 10, 2018 Safe Harbor This presentation is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the
More informationRTIX Investor Presentation
RTIX Investor Presentation Camille Farhat President and CEO Jonathon Singer CF&AO September 2018 Forward Looking Statements This communication contains forward-looking statements within the meaning of
More informationTriNet Group, Inc. Investor Presentation November 2017
TriNet Group, Inc. Investor Presentation November 2017 Disclaimer Cautionary Note Regarding Forward-Looking Statements and Other Financial Information This presentation contains statements that are not
More informationCanaccord Genuity Musculoskeletal Conference San Francisco, CA February 7, Integra LifeSciences Corporation. All rights reserved.
Canaccord Genuity Musculoskeletal Conference San Francisco, CA February 7, 2012 2012 Integra LifeSciences Corporation. All rights reserved. Safe Harbor Statement Certain statements made in this presentation
More informationInvestor Presentation. November 2016
Investor Presentation November 2016 Safe Harbor Statement The statements in this presentation that relate to guidance, pro forma presentations, future plans, goals, business opportunities, events or performance
More informationCEO s Round Table June
CEO s Round Table June 2009 0 Forward looking statements This presentation contains certain "forward-looking statements" within the meaning of the US Private Securities Litigation Reform Act of 1995. In
More informationLEVERAGING OUR BIOLOGICS EXPERTISE IN BIOSIMILARS SCOTT FORAKER VICE PRESIDENT AND GENERAL MANAGER, BIOSIMILARS
LEVERAGING OUR BIOLOGICS EXPERTISE IN BIOSIMILARS SCOTT FORAKER VICE PRESIDENT AND GENERAL MANAGER, BIOSIMILARS SAFE HARBOR STATEMENT This presentation contains forward-looking statements that are based
More information21 st Annual Needham Growth Conference. January 15, 2019
21 st Annual Needham Growth Conference January 15, 2019 Forward-Looking Statements Certain statements in this communication may contain forward-looking statements within the meaning of the Private Securities
More informationFourt r h t Q u Q art ar er Fiscal scal Y ear ear 2011 Fin i ancial ci al Result l s
Fourth Quarter Fiscal Year 2011 Financial Results June 9, 2011 1 Forward Looking Statements Certain statements included in this management presentation constitute forward-looking statements, including
More informationRefrigerants, Recycling & Energy Efficiency
Refrigerants, Recycling & Energy Efficiency NASDAQ: HDSN May 2018 1 Safe Harbor Statement Statements contained herein which are not historical facts constitute forward-looking statements. These include
More informationUnlocking Our Growth Opportunity
Unlocking Our Growth Opportunity Thomas Seifert EVP and Chief Financial Officer Forward Looking Statements This presentation contains statements regarding our projected financial and business results,
More informationTriNet Group, Inc. Investor Presentation March 2018
TriNet Group, Inc. Investor Presentation March 2018 Disclaimer Cautionary Note Regarding Forward-Looking Statements and Other Financial Information This presentation contains statements that are not historical
More informationJefferies 2014 Global Healthcare Conference June 3, 2014 NYSE: Q
Jefferies 2014 Global Healthcare Conference June 3, 2014 NYSE: Q Copyright 2013 Quintiles Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains forward-looking statements
More informationMORGAN STANLEY LAGUNA CONFERENCE Dan Comas September 15, 2016
MORGAN STANLEY LAGUNA CONFERENCE Dan Comas September 15, 2016 Forward Looking Statements Statements in this presentation that are not strictly historical, including any statements regarding events or developments
More informationTriNet Group, Inc. Investor Presentation August September 2018
TriNet Group, Inc. Investor Presentation August September 2018 Disclaimer Cautionary Note Regarding Forward-Looking Statements and Other Financial Information This presentation contains statements that
More informationInvestor Presentation May 2018
Investor Presentation May 2018 FORWARD-LOOKING STATEMENTS Forward-Looking Statements Certain statements and information in this communication may be deemed to be forward-looking statements within the meaning
More informationExtreme Networks FQ2 18 Financial Results
Extreme Networks FQ2 18 Financial Results February 6, 2018 Cautionary Statement on Financial Measures Non-GAAP Measures: In preparing the accompanying information, the Company has excluded, where applicable,
More informationaap Implantate AG Corporate Presentation German Equity Forum 2018 Bruke Seyoum Alemu, CEO Marek Hahn, CFO
aap Implantate AG Corporate Presentation German Equity Forum 2018 Making Trauma Treatment Better and Cost-Effective Bruke Seyoum Alemu, CEO Marek Hahn, CFO Frankfurt am Main, November 27, 2018 Safe Harbor
More informationThe Future of Consumer Health Care
The Future of Consumer Health Care Coming Together To Lead The Consumer Health Care Industry 2 Creating a New Business Model in Consumer Health Care 3 Serve More Consumers In More Parts of the World, More
More informationBaird 2018 Global Industrial Conference. Jim Lico President & CEO
Baird 2018 Global Industrial Conference Jim Lico President & CEO FORWARD-LOOKING STATEMENTS & NON-GAAP FINANCIAL MEASURES Statements in this presentation that are not strictly historical, statements regarding
More informationSecurities Analyst Meeting 2017 PRINTING. Enrique Lores President, Imaging and Printing Business
Securities Analyst Meeting 2017 PRINTING Enrique Lores President, Imaging and Printing Business Forward-looking statements Today s presentations contain forward-looking statements that involve risks, uncertainties
More informationMindray Medical International Limited Acquisition of Datascope PMB Business. March 2008
Mindray Medical International Limited Acquisition of Datascope PMB Business March 2008 Disclaimer This material contains forward-looking statements with respect to the Company's plans to complete the acquisition
More informationSupplemental Financial Schedules May 19, 2015
Supplemental Financial Schedules May 19, 2015 The presentations and related schedules contain financial measures that are not calculated in accordance with generally accepted accounting principles (GAAP).
More informationDisclaimer Forward-Looking Statements Industry and Market Data Non-GAAP Financial Information
Disclaimer Forward-Looking Statements This presentation includes forward-looking statements within the meaning of the Securities Act of 1933, as amended (the Securities Act ), the Securities Exchange Act
More informationCommerceHub Investor Presentation
CommerceHub Investor Presentation Winter 2017-2018 1 FORWARD-LOOKING INFORMATION This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act
More informationTriNet Group, Inc. William Blair Growth Company Conference June 2017
TriNet Group, Inc. William Blair Growth Company Conference June 2017 Disclaimer Cautionary Note Regarding Forward-Looking Statements and Other Financial Information This presentation contains statements
More informationSTRYKER ANALYST MEETING. September 2014
STRYKER ANALYST MEETING September 2014 FORWARD LOOKING STATEMENT Certain statements made in the presentation may contain information that includes or is based on forward-looking statements within the meaning
More informationInvestor Slides. Needham 20 th Annual Growth Conference January 17, 2018 NASDAQ GS: UEIC
Investor Slides Needham 20 th Annual Growth Conference January 17, 2018 NASDAQ GS: UEIC Safe Harbor Statement During this presentation, Management will reference Adjusted Non-GAAP information, including
More informationAnika Therapeutics, Inc.
Anika Therapeutics, Inc. Canaccord Genuity 34th Annual Growth Conference August 14 th, 2014 Safe Harbor Statement The statements made in this presentation, which are not statements of historical fact,
More informationJEFFERIES 2015 GLOBAL HEALTHCARE CONFERENCE JUNE 3, 2015 NACHUM HOMI SHAMIR PRESIDENT AND CHIEF EXECUTIVE OFFICER
JEFFERIES 2015 GLOBAL HEALTHCARE CONFERENCE JUNE 3, 2015 NACHUM HOMI SHAMIR PRESIDENT AND CHIEF EXECUTIVE OFFICER SAFE HARBOR STATEMENT Certain statements made during the course of this presentation may
More information37 th Annual J.P. Morgan Healthcare Conference. January 9, 2019
37 th Annual J.P. Morgan Healthcare Conference January 9, 2019 Forward-Looking Statements and Non-GAAP Financial Measures This presentation includes information that may constitute forward-looking statements,
More informationFORWARD LOOKING STATEMENT
FORWARD LOOKING STATEMENT Statements made in this presentation that look forward in time or that express management's beliefs, expectations, hopes or predictions of the future are forward-looking statements
More informationThe New SEPTEMBER 2018 MARCH
The New SEPTEMBER 2018 MARCH 2018 1 Forward-Looking Statements This communication contains forward-looking statements within the meaning of the federal securities laws. In this context, forwardlooking
More informationWelcome to Synchronoss 3.0
Welcome to Synchronoss 3.0 Intralinks Acquisition Overview and Activation Divestiture December 6, 2016 1 2016 Synchronoss, Inc. All Rights Reserved Safe Harbor. Forward-Looking Statements This presentation
More informationBlueLinx Second Quarter 2018 Earnings Webcast
BlueLinx Second Quarter 2018 Earnings Webcast Notes To Investors Forward-Looking Statements. This presentation includes forward-looking statements within the meaning of the Private Securities Litigation
More informationCFO Commentary on First-Quarter 2013 Results
Intel Corporation 2200 Mission College Blvd. Santa Clara, CA 95054-1549 CFO Commentary on First-Quarter 2013 Results Summary First quarter revenue of $12.6B was down 7% sequentially, in line with the average
More informationWINDSTREAM CORPORATION UNAUDITED CONSOLIDATED STATEMENTS OF INCOME (In millions, except per share amounts)
(A) (B) (C) (D) WINDSTREAM CORPORATION UNAUDITED CONSOLIDATED STATEMENTS OF INCOME (In millions, except per share amounts) THREE MONTHS ENDED SIX MONTHS ENDED Increase Increase June 30, June 30, (Decrease)
More informationWESTFALIA AUTOMOTIVE ACQUISITION AUGUST 25, 2016
WESTFALIA AUTOMOTIVE ACQUISITION AUGUST 25, 2016 1 SAFE HARBOR STATEMENT FORWARD-LOOKING STATEMENTS This presentation may contain "forward-looking statements" as defined in the Private Securities Litigation
More informationFirst Quarter 2017 Earnings. May 9, 2017
First Quarter 2017 Earnings May 9, 2017 1 Safe Harbor Caution Concerning Forward-Looking Statements Various remarks that the Company makes contain forward-looking statements regarding acquisitions, acquisition
More informationJP Morgan Healthcare Conference. 11 January 2010
JP Morgan Healthcare Conference 11 January 2010 Forward looking statements This presentation contains certain "forward-looking statements" within the meaning of the US Private Securities Litigation Reform
More informationInvestor Relations Presentation. September 2014
Investor Relations Presentation September 2014 Forward Looking Statements This presentation contains historical information and forward-looking statements within the meaning of The Private Securities Litigation
More informationPrecision Engineered Products Acquisition August 17, 2015
Precision Engineered Products Acquisition August 17, 2015 Forward-Looking Statements and Non-GAAP Financial Information Forward Looking Statements: With the exception of the historical information contained
More informationNASDAQ: EYES. Investor Presentation
Investor Presentation 2016 Forward Looking Statements This presentation contains certain forward looking information about Second Sight that is intended to be covered by the safe harbor for "forward looking
More informationSafe Harbor Statement & Non-GAAP Information
1 Safe Harbor Statement & Non-GAAP Information This presentation should be viewed in conjunction with PepsiCo s webcast presentation at the Consumer Analyst Group of New York Conference on February 20,
More informationEveryday Health. Investor Call December 5, 2016
Everyday Health Investor Call December 5, 2016 Safe Harbor for Forward-Looking Statements Certain statements in this presentation are forward-looking statements within the meaning of the Private Securities
More informationAvery Dennison Investor Presentation August 2014
Avery Dennison Investor Presentation August 2014 Unless otherwise indicated, the discussion of the company s results is focused on its continuing operations, and comparisons are to the same period in the
More informationForward Guidance. Priceline.com issued the following guidance for the 2nd half of 2004:
Priceline.com Reports 2nd Quarter 2004 Financial Results; Gross Travel Bookings Are $470.4 Million, Up 58% Year Over Year; Airline Ticket Unit Bookings Grow 60% NORWALK, Conn.--(BUSINESS WIRE)--Aug. 2,
More informationScienti c Games Wins Belgium National Lottery's Instant Games in Competitive Bid
Scienti c Games Wins Belgium National Lottery's Instant Games in Competitive Bid Company Will Continue to Drive Lottery Revenue Growth in Europe with Innovation, Marketing Support and Global Best Practices
More informationCanadian Tire Corporation to Acquire Helly Hansen
Canadian Tire Corporation to Acquire Helly Hansen May 2018 Forward-Looking Statement This presentation contains forward-looking information within the meaning of applicable securities legislation, which
More informationFY2015 Results Presentation CEO & Managing Director - Julian Ogrin CFO - Leanne Wolski
FY2015 Results Presentation CEO & Managing Director - Julian Ogrin CFO - Leanne Wolski 21 August 2015 Important notice and disclaimer This presentation includes information about the activities of amaysim
More informationINVESTOR PRESENTATION. August 2016
INVESTOR PRESENTATION August 2016 Forwards Looking Statement Disclaimer This presentation contains statements, including statements about future plans and expectations, which constitute forwardlooking
More informationSupplemental Schedules for Q1-18 Earnings Release
Supplemental Schedules for Q1-18 Earnings Release April 4, 2018 Schedule 1 Q1 2018 Homebuilding Metrics, as Reported and Pro Forma Exhibit 99.2 Lennar Standalone (12/1/17-2/28/18) CalAtlantic (2/13/18-2/28/18)
More information37 th Annual J.P. Morgan Healthcare Conference
37 th Annual J.P. Morgan Healthcare Conference Ronald Rittenmeyer, Executive Chairman and CEO January 8, 2019 1 FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements. These statements
More informationAlliqua BioMedical Investor Presentation August 2017 NASDAQ: ALQA
Alliqua BioMedical Investor Presentation August 2017 NASDAQ: ALQA Forward Looking Statements Safe Harbor Statement This presentation contains forward-looking statements. Forward-looking statements are
More information3 rd Quarter 2018 Financial Results
3 rd Quarter 2018 Financial Results Earnings Conference Call and Webcast 1 Safe Harbor Statement This report contains forward-looking statements within the meaning of the Private Securities Litigation
More informationInvestor Presentation
Investor Presentation June 2018 Safe Harbor Statement All statements, other than statements of historical fact included in this presentation, are forward-looking statements. When used in this presentation,
More informationJefferies 2015 Global Healthcare Conference June 3, 2015
Jefferies 2015 Global Healthcare Conference June 3, 2015 Forward-Looking Statements This document may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act
More informationPfizer Completes Acquisition of Hospira
For immediate release: September 3, 2015 Media Contact: Joan Campion (212) 733-2798 Investor Contact: Chuck Triano (212) 733-3901 Pfizer Completes Acquisition of Hospira Creates a leading Global Established
More informationAgilent Technologies. Q2 15 Results Presentation. Page 1
Agilent Technologies Q2 15 Results Presentation Page 1 Safe Harbor This presentation contains forward-looking statements (including, without limitation, information and future guidance on the company s
More information2010 ANSYS, Inc. All rights reserved. 1 ANSYS, Inc. Proprietary
Apache Transaction Highlights June 30, 2011 2010 ANSYS, Inc. All rights reserved. 1 ANSYS, Inc. Proprietary Safe Harbor Statement Certain statements contained in this presentation regarding matters that
More informationSTRATASYS Q May 9 th, 2016 FINANCIAL RESULTS CONFERENCE CALL 1 STRATASYS / THE 3D PRINTING SOLUTIONS COMPANY
STRATASYS Q1 2016 FINANCIAL RESULTS CONFERENCE CALL May 9 th, 2016 1 STRATASYS / THE 3D PRINTING SOLUTIONS COMPANY Q1 2016 Conference and webcast details Speakers David Reis CEO Erez Simha COO & CFO Shane
More informationVishay Precision Group
Vishay Precision Group August 2018 Safe Harbor Statement From time to time, information provided by us, including but not limited to statements in this report, or other statements made by or on our behalf,
More informationFinancial Discussion. James Kavanaugh Senior Vice President and Chief Financial Officer IBM
Financial Discussion James Kavanaugh Senior Vice President and Chief Financial Officer IBM 1 IBM 2018 Investor Briefing Our differentiated value proposition is driven by innovative technology, industry
More informationQ1 FY19 Financial Update
Q FY9 Financial Update Salesforce NYSE: CRM @Salesforce_ir Safe Harbor "Safe harbor" statement under the Private Securities Litigation Reform Act of 995: This presentation contains forward-looking statements
More informationTHE GLOBAL HOUSE OF PRESTIGE BEAUTY FABRIZIO FREDA PRESIDENT AND CEO THE ESTÉE LAUDER COMPANIES ANNUAL STOCKHOLDERS MEETING
THE GLOBAL HOUSE OF PRESTIGE BEAUTY FABRIZIO FREDA PRESIDENT AND CEO THE ESTÉE LAUDER COMPANIES ANNUAL STOCKHOLDERS MEETING NOVEMBER 11, 2016 FORWARD-LOOKING INFORMATION THE FORWARD-LOOKING STATEMENTS
More informationAcquisition of KLX Inc.
Acquisition of KLX Inc. May 1, 2018 Forward-Looking Information Forward-Looking Information Is Subject to Risk and Uncertainty Certain statements in this document may be forward-looking within the meaning
More informationUBS 2007 Global Life Sciences Conference. September 24, 2007
UBS 2007 Global Life Sciences Conference September 24, 2007 Safe Harbor This presentation contains "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 and Section
More informationMomenta Pharmaceuticals Reports First Quarter 2017 Financial Results
May 2, 2017 Momenta Pharmaceuticals Reports First Quarter 2017 Financial Results --Company reports Glatopa 20 mg product revenues of $23 million, a 58% increase over the same period in 2016-- --Ended the
More informationProgress Software Reports 2010 Second Quarter Results
June 22, 2010 Progress Software Reports 2010 Second Quarter Results Non-GAAP Total Revenue Up 9%; Non-GAAP Earnings per Share Up 51%; Enterprise Business Solutions Revenue Up 39% BEDFORD, MA, Jun 22, 2010
More informationSpeech Nancy McKinstry Annual General Meeting of Shareholders 2008 April 22, 2008 Okura Hotel Amsterdam
Speech Nancy McKinstry Annual General Meeting of Shareholders 2008 April 22, 2008 Okura Hotel Amsterdam Welcome and good morning. It is a pleasure to be here today to share our 2007 results and provide
More informationCISCO SYSTEMS, INC. Q4 FY 2004 CONFERENCE CALL
CISCO SYSTEMS, INC. Q4 FY 2004 CONFERENCE CALL August 10, 2004 2004, Cisco Systems, Inc. All rights reserved. 1 GAAP Reconciliation and Forward-Looking Statements GAAP RECONCILIATION During this presentation
More informationTHERMO FISHER SCIENTIFIC
THERMO FISHER SCIENTIFIC February 8, 2007 Reconciliation of Financial Information Q4-2006 1. GAAP P&L (as reported): 2002 to 2006 2. Reconciliation of GAAP to Adjusted P&L: 2002 to 2006 3. Business Segment
More informationThe Global Exchange For Advertising April 2018
The Global Exchange For Advertising April 2018 1 COPYRIGHT RUBICON PROJECT 2018 Safe Harbor Forward-Looking Statements This presentation includes, and management's answers to questions during the conference
More informationTo our fellow shareholders,
BIOCARDIA, INC. To our fellow shareholders, Another year is completed and I remain optimistic about the strength of our therapeutic programs and the progress we are making. There is intense effort being
More informationIntel Acquires Mobileye Frequently Asked Questions
Intel Acquires Mobileye Frequently Asked Questions Background: On March 13, Intel Corporation (NASDAQ: INTC) and Mobileye N.V. (NYSE: MBLY) announced a definitive agreement under which Intel would acquire
More informationInvestment Community Conference Call. First Quarter, 2017 Earnings May 4, 2017
Investment Community Conference Call First Quarter, 2017 Earnings May 4, 2017 Use of Non-GAAP Financial Information Diebold Nixdorf has included non-gaap financial measures in this presentation to supplement
More informationExane BNP Paribas Conference 10 May 2010
Exane BNP Paribas Conference 10 May 2010 Forward looking statements This presentation contains certain "forward-looking statements" within the meaning of the US Private Securities Litigation Reform Act
More informationFocusing Our Portfolio & Utilizing Our Financial Strength
Focusing Our Portfolio & Utilizing Our Financial Strength Bank of America Merrill Lynch 2017 Asia Pacific Telecom, Media & Technology Conference Ann Nicholson Division Vice President, Investor Relations
More informationInvestor Presentation RBC Capital Markets Global Healthcare Conference February 22, 2017
Investor Presentation 2017 RBC Capital Markets Global Healthcare Conference February 22, 2017 Forward-Looking Statements This document may contain forward-looking statements within the meaning of the Private
More information